Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats

Framroze R Billimoria1, Surendra S Katyare, Samir P Patel

  • 1Department of Biochemistry, Terna Medical College, Nerul, Navi Mumbai, India.

Insights

Diabetic women face higher heart disease risks. This study reveals sex-specific mitochondrial dysfunction in diabetes, with insulin treatment showing differential effects in male and female rats, potentially explaining increased female cardiomyopathy incidence.

Area of Science:

  • Biochemistry
  • Cardiology
  • Endocrinology

Background:

  • Diabetic patients exhibit higher rates of coronary heart disease (CHD), congestive heart failure (CHF), and myocardial infarction compared to non-diabetic individuals.
  • These cardiovascular complications are notably more prevalent in women than in men.

Purpose of the Study:

  • To investigate the role of mitochondrial energy transduction in the increased incidence of cardiovascular diseases in diabetic women.
  • To examine the effects of insulin treatment on mitochondrial function in a rat model of diabetes.

Main Methods:

  • Utilized streptozotocin (STZ)-induced diabetic male and female rats to model diabetic cardiomyopathy.
  • Assessed mitochondrial energy metabolism, including respiration rates, cytochrome content, and dehydrogenase activities.
  • Evaluated the impact of two different insulin treatment regimens.

Main Results:

  • Diabetes decreased body and heart weights in both sexes; insulin partially restored these in females.
  • Mitochondrial respiration and substrate oxidation were impaired in diabetic rats, with insulin showing differential effects between sexes.
  • Insulin-induced hyper-stimulation of respiration in females may increase reactive oxygen species production, contributing to cardiovascular risk.

Conclusions:

  • Sex-specific differences in mitochondrial energy metabolism and response to insulin treatment in STZ-diabetic rats may underlie the higher incidence of diabetic cardiomyopathy in females.
  • Advanced glycosylation end products may further exacerbate cardiovascular risk in diabetic individuals.
Abstract

Related Concept Videos